Tower Research Capital LLC (TRC) - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 38 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$54,000
-78.6%
2,948
-78.5%
0.00%
-33.3%
Q3 2020$252,000
+486.0%
13,739
+382.1%
0.00%
+50.0%
Q2 2020$43,000
+2050.0%
2,850
+2092.3%
0.00%
Q4 2019$2,000
-88.9%
130
-89.2%
0.00%
-100.0%
Q3 2019$18,000
+12.5%
1,203
+28.1%
0.00%0.0%
Q1 2019$16,000
+45.5%
939
+67.1%
0.00%0.0%
Q3 2018$11,000
+120.0%
562
+24.1%
0.00%0.0%
Q4 2017$5,000
+25.0%
453
+28.7%
0.00%
Q3 2017$4,000
-75.0%
352
-80.7%
0.00%
-100.0%
Q2 2017$16,000
+60.0%
1,825
+110.3%
0.00%
+100.0%
Q2 2016$10,000
+900.0%
868
+2793.3%
0.00%
Q1 2016$1,000
-66.7%
30
-77.1%
0.00%
Q4 2015$3,000
-95.5%
131
-96.7%
0.00%
-100.0%
Q3 2015$67,000
+644.4%
3,973
+1627.4%
0.01%
+600.0%
Q2 2015$9,000
-40.0%
230
-50.3%
0.00%
-50.0%
Q1 2015$15,000
+275.0%
463
+172.4%
0.00%
Q3 2014$4,0001700.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q3 2015
NameSharesValueWeighting ↓
S. MUOIO & CO. LLC 40,000$734,0000.83%
WATER ISLAND CAPITAL LLC 133,286$2,444,0000.21%
Walleye Capital LLC 90,666$1,663,0000.18%
GLAZER CAPITAL, LLC 202,158$3,708,0000.18%
First Trust Capital Management L.P. 35,613$653,0000.18%
EQUITEC PROPRIETARY MARKETS, LLC 12,500$229,0000.18%
EQUITEC PROPRIETARY MARKETS, LLC 10,600$194,0000.15%
Olympiad Research LP 13,484$247,0000.13%
Yakira Capital Management, Inc. 17,588$323,0000.10%
Alpine Global Management, LLC 25,000$459,0000.10%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders